1. Real-world efficacy and safety of lenvatinib: data from a compassionate use in the treatment of radioactive iodine-refractory differentiated thyroid cancer patients in Italy. (September 2019) Authors: Locati, L.D.; Piovesan, A.; Durante, C.; Bregni, M.; Castagna, M.G.; Zovato, S.; Giusti, M.; Ibrahim, T.; Puxeddu, E.; Fedele, G.; Pellegriti, G.; Rinaldi, G.; Giuffrida, D.; Verderame, F.; Bertolini, F.; Bergamini, C.; Nervo, A.; Grani, G.; Rizzati, S.; Morelli, S. Journal: European journal of cancer Issue: Volume 118(2019) Page Start: 35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Screening and detecting significant liver fibrosis in patients with NAFLD: A practical approach using non-invasive tests. (March 2021) Authors: Alterini, G.; Sacco, P.; Formichi, C.; Ciuoli, C.; Ceccarelli, E.; Gonnelli, S.; Volterrani, L.; Castagna, M.G.; Dotta, F.; Brillanti, S. Journal: Digestive and liver disease Issue: Volume 53:(2021)Supplement 1 Page Start: S31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗